[A Randomized Controlled Multi-center Clinical Trial on Mosapride in the Treatment of Functional Dyspepsia].
Shi-yao Chen,Ji-yao Wang,Chou-wen Zhu,Yao-zong Yuan,Bing Zou,Lu Xia,Ji-yong Liu,Hong-wei Xu,Shang-zhong Zhang,Qing Wang,Xiang-jun Xie,Zhi-quan Zhao,Lin,Nai-zhong Hu,Jian-ming Xu
DOI: https://doi.org/10.3760/j.issn:0254-6450.2004.02.020
2004-01-01
Abstract:OBJECTIVE:To evaluate the effectiveness and safety of mosapride on treatment of functional dyspepsia.METHODS:Randomized controlled clinical trial was conducted and patients suffered from functional dyspepsia were included. 5 mg mosapride was given three times daily for 4 weeks in the treatment group. 10 mg domperidone was given three times daily for 4 weeks as control. Changes on symptom score, gastric empty or new occurring events were included as outcomes.RESULTS:231 patients suffered from functional dyspepsia were selected by inclusion and exclusion criteria from August 15 to Oct 22, 1999. Of these, 108 (46.8%) were males, versus 123 (53.2%) females and 118 (51.2%) in the treatment group and 113 (48.9%) as controls. 222 (96.1%) patients were followed up. Results showed that the total efficacy rates in early satiety and abdominal distension were 84.5% and 90.1% in mosapride after the 2 weeks of treatment. Mosapride seemed to be more effective in improving symptoms of belching and heartburn than that in controls (P < 0.05). In 4 weeks, the total efficacy in improving symptoms of abdominal distention and belching showed more effective in mosapride than that in controls (P < 0.05). Decrease of symptoms score was more in mosapride than that in controls (P < 0.05). Mosapride was less effective in controls in improving the gastric empty in terms of proportion (46.2% vs. 25.9%, P = 0.020) and range (46.2% vs. 24.0%, P = 0.003). Side effects would include diarrhea, constipation, headache, dizziness, insomnia, skin scare and the like. There was no significant difference between the two groups (9.6% in mosapride vs. 14.0% in controls).CONCLUSION:Mosapride was safe and effective in improving the symptoms and gastric empty of functional dyspepsia.